ClinicalTrials.gg
CompletedNCT00437593Updated Sep 23, 2008

UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue

An interventional study of ppVE, MP, ICG and ppVE, MP, MB in Retinal Diseases, sponsored by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery. Completed at 1 site in Austria. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-09-23.

Sponsored by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Using the UHR-OCT and HD-OCT to evaluate early postoperative changes in patients with diagnosis preretinal membrane after successfully performed pars-plana vitrectomy and membrane peeling with two different types of dyes.

Read the detailed description

Surgical procedures performed are pars-plana vitrectomy and membrane peeling with or without cataract extraction and IOL implantation. The type of the dyes is randomized. The study is designed to include a total of tweny cases (10 cases with ICG and 10 cases with Membrane blue)

Main outcome measures are:

UHR-OCT, HD-OCT distance and near visual acuity and contrast sensitivity amsler grid secondary outcome measures are: OCT Stratus 3000 and visual field. Clinical examinations: preoperative, and follow-up examinations after 1 week, 1 months, 3 months, 6 months and 12 months.

02

Conditions studied

  • Retinal Diseases

Keywords

  • preretinal membrane
  • vitrectomy
  • uhr-oct
  • hd-oct
03

In context

Retinal Diseases

817 studies on the registry are indexed under Retinal Diseases; 104 are open to participants now.

This study's planned enrollment of 20 is below the median of 60 across 502 interventional studies indexed under Retinal Diseases.

Browse Retinal Diseases studies →

Lead sponsor

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery is the lead sponsor of 23 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Preretinal membrane
  • Age between 18 and 85 years
  • Combined surgery possible(phacoemulsification and vitreoretinal procedure)

Exclusion criteria

Exclusion Criteria:

  • Age-related macular degeneration
  • Previous retinal detachment surgery
  • Previous laser treatment
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Interventions

  • ProcedureppVE, MP, ICG

    surgery with ILM staining

  • ProcedureppVE, MP, MB

    Surgery with ERM staining

06

What researchers measure

Primary outcomes

  1. UHR-OCT HD-OCT

    Time frame: 12 months

  2. Distance Visual acuity

    Time frame: 12 months

  3. Near Visual acuity

    Time frame: 12 months

  4. Contrast sensitivtiy

    Time frame: 12 months

Secondary outcomes

  1. OCT Stratus 3000

    Time frame: 12 months

  2. Visual Field

    Time frame: 12 months

07

Study locations

1 site
  • Rudolf Foundation Clinic
    Vienna, State of Vienna 1030, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00437593
Lead sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
First posted
Feb 21, 2007
Start date
Sep 2005
Primary completion
May 2008
Completion
May 2008
Last update
Sep 23, 2008

Study contacts

Susanne Binder, MD
study chair · Ludwig Boltzmann Institue for Retinology and Biomicroscopic Lasersurgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion